Security Snapshot

PETMED EXPRESS INC - Common Stock, par value $.001 per share (PETS) Institutional Ownership

CUSIP: 716382106

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

26

Shares (Excl. Options)

3.47MFull value: 3,466,597 · shares · 30 Sep 2026

Price

$1.38

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-110,444
Value change
-$206,762
Number of holders
26
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
22,120,455
SEC-reported price per share
$1.20
Insider filing price
$1.20
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • PETS - PETMED EXPRESS INC - Common Stock, par value $.001 per share is tracked under CUSIP 716382106.
  • 26 institutions reported positions in Q3 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 48 to 26 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $8.92MFull value: $8,921,325 · USD · 30 Jun 2026
    to
    $4.83MFull value: $4,826,371 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 26 institutions filings for Q3 2026.

Open SEC evidence

Security key

716382106

13F reference period

Q3 2026

13F holders

26

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
PETS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Silvercape Investments Ltd 12% -1.8% $5,623,737 2,579,696 0% SilverCape Investments Limited 29 Jun 2026
RENAISSANCE TECHNOLOGIES LLC 4.8% -9% $1,477,469 -$83,628 1,070,630 -5.4% Renaissance Technologies LLC 01 Jul 2026
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 4.7% $3,389,878 974,103 Hotchkis and Wiley Capital Management, LLC 31 Dec 2024
VANGUARD GROUP INC 4.7% $3,354,901 964,052 The Vanguard Group 31 Dec 2024
Diveroli Investment Group LLC 1.8% $1,300,633 391,757 Diveroli Investment Group LLC 11 Jan 2025
As of 30 Sep 2026, 26 institutional investors reported holding
3.47MFull value: 3,466,597 · shares · 30 Sep 2026
shares of PETMED EXPRESS INC - Common Stock, par value $.001 per share (PETS). This represents 16% of the company’s total
22.12MFull value: 22,120,455 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 21 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
15%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
RENAISSANCE TECHNOLOGIES LLC 4.8% 1,070,630 0% $1,477,469
VANGUARD CAPITAL MANAGEMENT LLC 3.7% 827,397 0% $1,141,808
TUDOR INVESTMENT CORP ET AL 1.1% 251,604 0% $347,214
STEEL PARTNERS HOLDINGS L.P. 0.88% 193,664 0.29% $267,256
GEODE CAPITAL MANAGEMENT, LLC 0.79% 175,665 0% $242,506
STATE STREET CORP 0.63% 138,273 0% $190,817
FEDERATED HERMES, INC. 0.59% 131,196 0% $181,050
VANGUARD FIDUCIARY TRUST CO 0.5% 110,481 0% $152,464
Empowered Funds, LLC 0.47% 104,841 0% $144,681
Formidable Asset Management, LLC 0.35% 78,451 0.02% $150,626
DIMENSIONAL FUND ADVISORS LP 0.27% 60,353 0% $83,301
Rangeley Capital, LLC 0.27% 58,855 0.11% $81,220
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.17% 38,603 0% $53,272
XTX Topco Ltd 0.12% 27,630 0% $38,129
IMC-Chicago, LLC 0.08% 18,243 0% $25,175
GOLDMAN SACHS GROUP INC 0.06% 12,383 0% $17,089
Vanguard Global Advisers, LLC 0.04% 8,120 0% $11,206
SBI Securities Co., Ltd. 0% 985 0% $1,359
Bank & Trust Co 0% 823 0% $1,136
Farther Finance Advisors, LLC 0% 151 0% $208
CoreCap Advisors, LLC 0% 4 0% $6

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 3,466,597 $4,826,371 -$206,762 $1.38 26
2026 Q2 4,630,213 $8,921,325 -$2,853,888 $1.92 48
2026 Q1 5,973,855 $13,717,489 -$2,446,794 $2.28 48
2025 Q4 6,958,110 $22,202,781 -$128,779 $3.20 50
2025 Q3 6,977,259 $17,594,055 -$1,201,821 $2.51 58
2025 Q2 7,375,436 $24,585,642 -$1,852,844 $3.32 64
2025 Q1 7,865,569 $32,955,520 -$4,830,840 $4.19 72
2024 Q4 8,975,229 $43,264,129 -$2,056,912 $4.82 86
2024 Q3 9,499,069 $34,955,912 -$9,644,338 $3.68 92
2024 Q2 12,062,004 $48,853,657 -$10,510,852 $4.05 116
2024 Q1 14,628,259 $70,068,794 -$7,859,398 $4.79 112
2023 Q4 15,509,467 $117,253,738 +$12,602,057 $7.56 129
2023 Q3 13,258,944 $135,901,539 -$32,574,245 $10.25 137
2023 Q2 15,760,896 $217,549,589 -$24,550,420 $13.79 148
2023 Q1 17,308,637 $281,093,086 +$9,030,233 $16.24 163
2022 Q4 16,715,209 $295,885,547 +$3,841,866 $17.70 158
2022 Q3 16,383,469 $319,884,926 -$27,418,578 $19.52 159
2022 Q2 17,760,121 $353,462,234 +$13,809,440 $19.90 158
2022 Q1 17,076,732 $440,712,342 +$3,458,908 $25.80 166
2021 Q4 16,949,737 $428,255,284 +$6,430,707 $25.26 171
2021 Q3 16,656,564 $447,492,163 -$30,441,331 $26.87 177
2021 Q2 17,710,744 $563,648,886 +$37,310,655 $31.85 187
2021 Q1 16,386,791 $575,952,684 -$52,856,316 $35.17 198
2020 Q4 18,057,333 $578,750,488 -$16,151,108 $32.06 204
2020 Q3 18,602,966 $587,963,793 -$9,681,690 $31.62 198
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .